Abstract

Crohn's disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required. Immunosuppressed patients are at increased risk for infections, including vaccine-preventable diseases such as influenza. Although several guidelines recommend routine influenza immunization for such patients, recent literature suggests that this patient population may be inadequately immunized. Current research suggests that inactivated influenza vaccines are effective, well tolerated and can be administered safely in most IBD patients. Studies in other immunosuppressed populations have also demonstrated the safety of inactivated vaccines. The present article reviews the literature regarding the safety and efficacy of influenza vaccination in IBD patients receiving immunosuppressive therapy.

Highlights

  • Crohn’s disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required

  • Crohn’s disease and ulcerative colitis are both variants of inflammatory bowel disease (IBD), and affect approximately 0.5% of Canadians [1]

  • It is generally accepted that an unknown environmental agent(s) and a dysfunctional mucosal immune system in genetically susceptible individuals leads to the development of either Crohn’s disease or ulcerative colitis [2]

Read more

Summary

Introduction

Crohn’s disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required. The risk of influenza infection and its complications is considered to be higher in patients undergoing immunosuppressive therapies [5]. Influenza is one of the most common vaccine-preventable illnesses in adults [8], and annual vaccination of immunosuppressed patients has been recommended by several agencies [5,8,9,10].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call